Combating chemoresistance amongst MYC amplified patients with neuroblastoma and medulloblastoma by inhibiting BRD4-MYC signalling axis (2024–2025)

Grant type:
TRI Leading Innovations through New Collaborations Scheme
Researchers:
  • Postdoctoral Research Fellow
    Frazer Institute
    Faculty of Medicine
    Postdoctoral Research Fellow
    Frazer Institute
    Faculty of Medicine
Funded by:
The Trustee for Translational Research Institute Trust